1. Market Overview
In 2025, the scale of China's efficacy skincare market exceeded RMB 150 billion, while the medical aesthetics market surpassed RMB 350 billion. Driven by both consumption upgrading and favorable policies, the industry continues to maintain double-digit growth.
2. Five Major Trends
Trend One: Recombinant Collagen Accelerates Substitution
With technological maturity and declining costs, recombinant collagen is accelerating its replacement of animal-derived collagen. It is estimated that by 2027, the penetration rate of recombinant collagen in the medical aesthetics market will exceed 60%.
Trend Two: Medicalization of Efficacy Skincare
Consumers have increasingly higher expectations for skincare efficacy, and efficacy skincare products backed by clinical data are gaining more favor. Medical device-grade skincare products have become a new growth point.
Trend Three: Personalized Customization
Personalized skincare solutions based on gene testing, skin analysis, and other technologies are becoming a trend, requiring OEM/ODM companies to possess stronger R&D and customization capabilities.
Trend Four: Accelerated Overseas Expansion
Chinese medical aesthetics brands and contract manufacturers are accelerating their overseas expansion, with emerging markets such as Southeast Asia and the Middle East becoming key targets. Multi-language and multi-regulatory-system product registration capabilities are becoming a core competitive advantage.
Trend Five: Green and Sustainable Development
Consumers are becoming more environmentally conscious, making green formulations, biodegradable packaging, and carbon-neutral production the new industry standards.
3. Weptide Bio's Strategic Layout
Now that we've discussed the trends, let's talk about how Weptide Bio is positioning itself.
First, let's look at our strengths: Weptide Bio currently holds more than 100 registration certificates, has passed the GMPC + ISO dual certification system, owns 72 patented technologies, and operates four production facilities with a combined area exceeding 100,000 square meters, with a daily output of 6 million units (pieces/bottles). This production capacity places us at the top tier in the efficacy skincare and medical aesthetics OEM/ODM sector.
In terms of full-process OEM/ODM services, Weptide's capability chain spans the entire spectrum—from independent R&D of active ingredients such as recombinant collagen, mussel adhesive protein, and ectoin at the raw material stage, to formulation design, efficacy verification, registration filing (Class II domestic medical devices + overseas registrations), and then to large-scale production and finished product delivery. The entire chain is closed-loop within our own operations. Brand owners no longer need to source suppliers from multiple places—one Weptide can handle it all.
Regarding overseas expansion, we have already accumulated extensive registration experience in Southeast Asian and Middle Eastern markets, and our multi-language, multi-regulatory-system product registration capability is becoming one of our core competitive advantages. In terms of green production, all four facilities are advancing carbon-neutral retrofits, with wastewater and exhaust gas treatment systems all upgraded to the latest standards.
4. Weptide's Solutions Under These Trends
With these five trends laid out, what brand owners care most about is "how do I seize these opportunities." From the perspective of a contract manufacturer, Weptide will break it down for you:
Recombinant Collagen Substitution Trend—Weptide's self-developed recombinant humanized type III collagen has a purity of ≥95%, and we have already obtained multiple relevant registration certificates (Xiangxie Zhunzhu 20222140503, Xiangxie Zhunzhu 20242140072, Qiongxie Zhunzhu 20252140091, etc.), allowing brand owners to quickly launch products based on mature solutions without going through the lengthy R&D cycle from scratch.
Medicalization of Efficacy Skincare Trend—Weptide leads the industry in the number of Class II medical device registration certificates, helping brand owners secure "medical device" certification status and backing product efficacy with clinical data, which is far more persuasive than purely cosmetic-certified products.
Personalized Customization Trend—Our library of 2,000+ proven formulations is not just for show; it's a truly usable ammunition depot. When brand owners need differentiation, Weptide can quickly deliver solutions, samples, and mass production.
Accelerated Overseas Expansion Trend—Weptide already has experience with overseas market registrations and can help brand owners handle product registration and compliance documentation in target countries, lowering the barriers to going global.
Green and Sustainable Development Trend—The green production systems at our four facilities are already fully operational. If brand owners choose Weptide for contract manufacturing, they will have substantial content to highlight in their ESG reports and brand stories.
5. Cooperation Cases
With all that said, nothing speaks louder than actual results. Weptide Bio has cumulatively served hundreds of brand clients. For our own brands, Shitaki, Shiweilandai, Beifu Factor, and Yiweilan are all product lines within the Weptide system.
6. Contact Us
Four Production Bases
- Guangzhou Weptide Factory: No. 77, Group 15, Dalang Village, Baiyunhu Street, Baiyun District, Guangzhou
- Guangdong Weptide Factory: No. 18 Taoyuan East Road, Songgang Songxia Industrial Park, Shishan Town, Nanhai District, Foshan City
- Guangdong Jinan Gene Factory: No. 23 Factory Building, Hongguang Industrial Park, No. 2 Wende Fifth Street, Zhaoqing High-tech Zone, Zhaoqing City, Guangdong Province
- Hunan Weptide Factory: Room 501, Building 11, Lanyuegu Smart Industrial Park, Xieyuan North Road, Ningxiang Economic Development Zone, Changsha City, Hunan Province
Brand owners are welcome to contact Weptide Bio to discuss your product plans—we'll help you bring them to life.
